Status:
COMPLETED
Use of a Behavioral Economic Intervention to Reduce Antibiotic Prescription for Upper Respiratory Infections
Lead Sponsor:
University of California, Los Angeles
Collaborating Sponsors:
LAC+USC Medical Center
Los Angeles County Department of Public Health
Conditions:
Antibiotics
Upper Respiratory Infections
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
In an effort to implement Choosing Wisely guidelines and decrease patient harm, we will implement and evaluate a clinician audit-feedback and behavioral "nudge" initiative to reduce low-value antibiot...
Detailed Description
National prescription rates for low-value antibiotics for uncomplicated upper respiratory infections (URIs) remain unacceptably high, including at LAC+USC Medical Center-one of the largest safety net ...
Eligibility Criteria
Inclusion
- all patient receiving treatment for Upper Respiratory Infections (defined by ICD codes EHR billable codes) at both LAC+USC Medical Center Urgent Care or Olive View-UCLA Medical Center
Exclusion
- Patients not receiving treatment for Upper Respiratory Infections at both LAC+USC Medical Center Urgent Care or Olive View-UCLA Medical Center
Key Trial Info
Start Date :
May 29 2015
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 30 2018
Estimated Enrollment :
2500 Patients enrolled
Trial Details
Trial ID
NCT03464279
Start Date
May 29 2015
End Date
March 30 2018
Last Update
May 2 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Los Angeles County +University of Southern California (LAC+USC) Medical Center
Los Angeles, California, United States, 90033